BioWest - Antibiotic-Antimycotic 100X

Hazard statements (CLP)

H302, H361

Code

Statements

H302

Harmful if swallowed

2.1 Classification of the substance or mixture

Directive 67/548/EC and Directive 1999/45/EC: This product was classified in accordance with Directive 67/548/EC and Directive 1999/45/EC, adapting the requirements to Regulation (EC) nº1907/2006 (REACH regulation). Repr. Cat 2: R61 - May cause harm to the unborn child (Category 2) Xn: R22 - Harmful if swallowed CLP Regulation (EC) nº 1272/2008: Classification of this product has been carried out in accordance with CLP Regulation (EC) nº 1272/2008. Acute Tox. 4: Acute toxicity if swallowed, Category 4, H302 Repr. 2: Reproductive toxicity, Category 2, H361

2.2 Label elements

Directive 67/548/EC and Directive 1999/45/EC: In accordance with the legislation, the elements on the label are as follows: T Toxic

R-phrase(s)

R22: Harmful if swallowed R61: May cause harm to the unborn child (Category 2)

S-phrase(s)

S38: In case of insufficient ventilation, wear suitable respiratory equipment S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible) S53: Avoid exposure - obtain special instructions before use

Supplemental label elements

P95 For professional use only "Warning -avoid exposure-. Obtain special instructions before use" P99: Contains sodium [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2- carboxylate. May cause an allergic reaction CLP Regulation (EC) nº 1272/2008: Warning EUH208: Contains sodium [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2- carboxylate. May produce an allergic reaction

Hazard statements

Acute Tox. 4: H302 - Harmful if swallowed Repr. 2: H361 - Suspected of damaging fertility or the unborn child

Precautionary statements

L0010 SECTION 2: HAZARDS IDENTIFICATION (continue) Non-applicable

2.3 Other hazards

Non-applicable